TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT03874767

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Patient Mobility
Description: A team of two mobility technicians will switch between two units on a monthly basis. The unit staffed by the mobility technician will be referred to as the intervention unit, while the other will be referred to as the control unit. One unit will start as the control unit and will switch to being the intervention unit after one month. Similarly, the other unit will start as the intervention unit and will switch to becoming the control unit after one month. All patients present on a unit during the intervention period will be provided mobility technician support according to standardized clinical guidelines that have been developed by the care team and described below. Patients who are present on a unit at the time of cross-over will not be included in the analysis, but will either no longer receive mobility technician support (if crossing from intervention to control) or will start to receive mobility technician support (if switching from control to intervention).

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Patient Mobility
Description: A team of two mobility technicians will switch between two units on a monthly basis. The unit staffed by the mobility technician will be referred to as the intervention unit, while the other will be referred to as the control unit. One unit will start as the control unit and will switch to being the intervention unit after one month. Similarly, the other unit will start as the intervention unit and will switch to becoming the control unit after one month. All patients present on a unit during the intervention period will be provided mobility technician support according to standardized clinical guidelines that have been developed by the care team and described below. Patients who are present on a unit at the time of cross-over will not be included in the analysis, but will either no longer receive mobility technician support (if crossing from intervention to control) or will start to receive mobility technician support (if switching from control to intervention).
Study: NCT05528406

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: HLX208
Description: 900mg bid po
Study: NCT06046066

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: NM6603
Description: NM6603 is an orally available investigational small molecule indicated for the treatment of solid malignancies including, but not limited to breast, liver, pancreatic, colorectal, cervical, melanoma and lung cancers.
Study: NCT04892706

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: IDP-126 Gel
Description: Gel applied to face once daily in the evening.

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: IDP-126 Vehicle Gel
Description: Gel applied to face once daily in the evening.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Epiduo® Forte Gel
Description: Gel applied to face once daily in the evening.
Study: NCT05962281

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Transcranial direct current stimulation (tDCS)
Description: Transcranial direct current stimulation (tDCS), a form of non-invasive brain stimulation which involves the use of low intensity currents propagated via the scalp, is widely implemented as both a fundamental and clinical neuroscientific tool. Over the last decades, tDCS showed significant therapeutic promise, as numerous studies revealed that it can result in improved attention and executive functions in patients with neurological disorders, through modification of neuronal excitability.

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Transcranial direct current stimulation (tDCS)
Description: Transcranial direct current stimulation (tDCS), a form of non-invasive brain stimulation which involves the use of low intensity currents propagated via the scalp, is widely implemented as both a fundamental and clinical neuroscientific tool. Over the last decades, tDCS showed significant therapeutic promise, as numerous studies revealed that it can result in improved attention and executive functions in patients with neurological disorders, through modification of neuronal excitability.

Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Transcranial direct current stimulation (tDCS)
Description: Transcranial direct current stimulation (tDCS), a form of non-invasive brain stimulation which involves the use of low intensity currents propagated via the scalp, is widely implemented as both a fundamental and clinical neuroscientific tool. Over the last decades, tDCS showed significant therapeutic promise, as numerous studies revealed that it can result in improved attention and executive functions in patients with neurological disorders, through modification of neuronal excitability.
Study: NCT05157061

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Galacto-oligosaccharides (GOS)
Description: An 8-week intervention study, preceded by a 2-week run-in period, in which a daily dose of a prebiotic supplement is given to adult patients diagnosed with IBS (diarrhoea, constipation or mixed-type). Patients need to report several symptom experiences and blood and faecal samples are collected.

Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Maltodextrine
Description: An 8-week intervention study, preceded by a 2-week run-in period, in which a daily dose of a placebo is given to adult patients diagnosed with IBS (diarrhoea, constipation or mixed-type). Patients need to report several symptom experiences and blood and faecal samples are collected.
Study: NCT05035043

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Determination of the economic burden NAFLD patients
Description: Determination of the economic burden NAFLD patients (Healthcare costs, patient costs, burden of disease
Study: NCT05346328

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Injection of A166
Description: 4.8 mg/kg for each 21 (±3) -day cycle
Study: NCT05526053

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Lung volume preservation
Description: Extubate the patient connected to the ventilator and PEEP of 5 cmH2O after a successful SBT also using PEEP.
Study: NCT06199128

Intervention type: DIETARY_SUPPLEMENT
Intervention: carboxymethyl β-glucan
Description: It is a vaginal spray gel designed for the prevention and treatment of cervical lesions caused by HPV. This is achieved by controlling the physiological conditions of the transformation zone of the cervico-vaginal mucosa. The composition of the gel, which includes polycarbophil and carboxymethyl-beta-glucan, effectively shields the cervico-vaginal mucosa from the damaging effects of external agents due to its bioadhesive capacity. Additionally, it contributes to the re-epithelialization and regression of cervical lesions
Study: NCT05460897

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Health behaviour change
Description: weekly sessions addressing strategies to tackle behavioural risk factors for chronic disease
Study: NCT05401513

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Pilates Group
Description: The individuals of the Pilates group will perform specific exercises of the method, which will involve mobility, stability and muscular resistance. The exercises will progress according to the level of difficulty (basic, intermediate and advanced), load and repetition every three or four weeks.
Study: NCT01053702

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: R475
Description: IV

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: R475
Description: IV

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo
Study: NCT05535309

Intervention type: DRUG
Intervention: cefoperazone sulbactam sodium
Description: Cefoperazone sodium and Sulbactam Sodium for injection (1; 1) are white or almost white powder drugs, and the components are cefoperazone sodium and sulbactam sodium

Intervention type: DRUG
Intervention: cefoperazone sulbactam sodium
Description: Cefoperazone sodium and Sulbactam Sodium for injection (1; 1) are white or almost white powder drugs, and the components are cefoperazone sodium and sulbactam sodium
Study: NCT06281379

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Total mesogastrectomy
Description: More extended resection type with better oncological outcomes when compared to standard technique

Intervention type: PROCEDURE
Group type: OTHER
Intervention: Total mesogastrectomy
Description: More extended resection type with better oncological outcomes when compared to standard technique
Study: NCT05626244

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Being a Parent
Description: Being a Parent (BaP) is a group parenting intervention for parents of children (2-11 years old) with behavioral problems. It consists of 2-hour sessions facilitated by psychologists for between 8-12 parents. Based on attachment, family systems, and cognitive-behavioral theories, BaP successfully integrates knowledge acquisition, behavior change with adult learning and social support. Each course session is highly interactive involving an engaging blend of small and large group discussion, role play, demonstrations, information sharing and reflection. This enables parents to practice and use new skills to achieve specific goals (Day et al., 2020).
Study: NCT05373212

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Euglycemic clamp with BC Combo THDB0207
Description: Administration of a single dose of BC Combo THDB0207 during an euglycemic clamp procedure.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Euglycemic clamp with BC Combo THDB0207
Description: Administration of a single dose of BC Combo THDB0207 during an euglycemic clamp procedure.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Euglycemic clamp with BC Combo THDB0207
Description: Administration of a single dose of BC Combo THDB0207 during an euglycemic clamp procedure.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Euglycemic clamp with Humalog® Mix25
Description: Administration of a single dose of Humalog® Mix25 during an euglycemic clamp procedure.
Study: NCT06049147

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: MBF-015 4 mg oral capsule
Description: MBF-015 oral capsules Histone deacetylase inhibitor

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: MBF-015 4 mg oral capsule
Description: MBF-015 oral capsules Histone deacetylase inhibitor

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: MBF-015 4 mg oral capsule
Description: MBF-015 oral capsules Histone deacetylase inhibitor

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: MBF-015 16 mg oral capsule
Description: MBF-015 oral capsules Histone deacetylase inhibitor

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: MBF-015 16 mg oral capsule
Description: MBF-015 oral capsules Histone deacetylase inhibitor

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: MBF-015 16 mg oral capsule
Description: MBF-015 oral capsules Histone deacetylase inhibitor

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: MBF-015 16 mg oral capsule
Description: MBF-015 oral capsules Histone deacetylase inhibitor
Study: NCT04987242

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ALLN-346
Description: ALLN-346 (Engineered Urate Oxidase) is an orally administered, novel urate oxidase; provided as capsules for oral administration

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Matched placebo capsules are similar in weight and appearance to the ALLN-346 capsules
Study: NCT05935436

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Cardiac Shock Wave Therapy
Description: When operating CSWT, it is necessary to determine the target myocardium for treatment, adjust the height of the water bladder, set the energy that the patient can tolerate, and then start the treatment. During the treatment, the vital signs of the subjects should be detected.

Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Cardiac Shock Wave Therapy
Description: When operating CSWT, it is necessary to determine the target myocardium for treatment, adjust the height of the water bladder, set the energy that the patient can tolerate, and then start the treatment. During the treatment, the vital signs of the subjects should be detected.
Study: NCT06049147

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: MBF-015 16 mg oral capsule
Description: MBF-015 oral capsules Histone deacetylase inhibitor

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: MBF-015 16 mg oral capsule
Description: MBF-015 oral capsules Histone deacetylase inhibitor

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Hard gelatin capsules filled with cellulose microcrystalline
Study: NCT05953571

Intervention type: PROCEDURE
Intervention: Dismembered Pyeloplasty
Description: dismembered Anderson-Hynes repair was performed using 5/0 absorbable suture.

Intervention type: PROCEDURE
Intervention: Dismembered Pyeloplasty
Description: dismembered Anderson-Hynes repair was performed using 5/0 absorbable suture.
Study: NCT05129787

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Surgical resection
Description: Resection of metastasis

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Thermal ablation
Description: Ablation of metastasis
Study: NCT06049147

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Hard gelatin capsules filled with cellulose microcrystalline
Study: NCT04951102

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Electronic Asthma Shared Decision-Making App
Description: The electronic Asthma SDM App will ask questions related to medicine-related, non-medicine-related, and COVID-19-related concerns about patients' asthma, the patients' personal goals for asthma control and expectation for their upcoming visit, and the patients' preferred level of details and involvement in coming to a decision about their asthma treatment. They may also use the Asthma SDM app to find information about asthma, medication management, COVID-19 and COVID-19 vaccines.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Shared Decision Making Physician Training Video
Description: Training video to educate physicians on Shared Decision-Making and the use of Shared Decision-Making tools.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Electronic Asthma Shared Decision-Making App- Patient Data
Description: Data from the pre-visit electronic Asthma SDM app completed by the patients. Data includes medicine-related, non-medicine-related, and COVID-related concerns about patients' asthma, the patients' personal goals for asthma control and expectation for their upcoming visit, and the patients' preferred level of details and involvement in coming to a decision about their asthma treatment.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Standard Care
Description: Standard Care for asthma.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Standard Care
Description: Standard Care for asthma.
Study: NCT04503941

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Acupuncture treatment
Description: Acupuncture treatment will be the Traditional Chinese Medicine type. Acupuncture 3 times per week, 4 weeks is one treatment period. Every patient will be given 3 treatment period.
Study: NCT05626985

Intervention type: DIAGNOSTIC_TEST
Intervention: GAMAD
Description: Blood samples are tested for tumor markers including PIVKA-II (DCP),AFP, ctDNA methylation and biochemical tests.

Intervention type: DIAGNOSTIC_TEST
Intervention: GAMAD
Description: Blood samples are tested for tumor markers including PIVKA-II (DCP),AFP, ctDNA methylation and biochemical tests.

Intervention type: DIAGNOSTIC_TEST
Intervention: GAMAD
Description: Blood samples are tested for tumor markers including PIVKA-II (DCP),AFP, ctDNA methylation and biochemical tests.

Intervention type: DIAGNOSTIC_TEST
Intervention: GAMAD
Description: Blood samples are tested for tumor markers including PIVKA-II (DCP),AFP, ctDNA methylation and biochemical tests.

Intervention type: DIAGNOSTIC_TEST
Intervention: GAMAD
Description: Blood samples are tested for tumor markers including PIVKA-II (DCP),AFP, ctDNA methylation and biochemical tests.
Study: NCT06239038

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: total knee arthroplasty
Description: total knee arthroplasty surgery with Police Arthroplasty joint academy center(PAJAC) Subvastus Approach

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: total knee arthroplasty
Description: total knee arthroplasty surgery with Police Arthroplasty joint academy center(PAJAC) Subvastus Approach
Study: NCT05389748

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Subjects with large vessel occlusion stroke eligible for mechanical thrombectomy are randomized to placebo in association with standard of care

Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: dodecafluoropentane emulsion (DDFPe)
Description: Subjects with large vessel occlusion stroke eligible for mechanical thrombectomy are randomized to DDFPe in association with standard of care
Study: NCT05143333

Intervention type: OTHER
Intervention: DANA app
Description: The Defense Automated Neurobehavioral Assessment (DANA) is a battery of cognitive tests delivered via an electronic tablet or smartphone. The platform allows higher temporal precision and frequency of measurement than traditional neuropsychological methods while including previously standardized cognitive tests and allowing individuals to repeatedly self-administer the battery in their own homes without examiner supervision. Hence, the DANA battery bypasses several of the major limitations associated with in-person cognitive exams.
Study: NCT04971967

Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: Crowdsourced partner services intervention
Description: The intervention includes the provision of provider referral and dual referral services, crowdsourced materials such as postcards and an HTML aiming to promote PS, as well as free take-home HIV self-testing kits.
Study: NCT06438185

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: IRE System
Description: Irreversible Electroporation (IRE) System for Inferior Turbinate Hypertrophy with Nasal Obstruction.
Study: NCT04853771

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: progressive muscle relaxation exercise training
Description: Progressive muscle relaxation exercises (PKGE); 16 large muscles (right hand and forearm, right upper arm, left hand and forearm of left arm, left upper arm, forehead, upper cheek and nose, chin, neck, abdomen, upper right arm, which people can do on their own after learning) leg, right calf, right foot, left upper leg, left thigh and left foot), followed by the contraction and then relaxation and accompanied by deep breathing, is a preferred method for reducing pain, anxiety and depression in individuals.The relaxation will be required to take 10-20 before stretching the next muscle group. In this way, the muscle groups in the hands, arms, neck, shoulder, chest, abdomen, hips, feet and fingers, face and the whole body will be voluntarily stretched and relaxed, and pregnant women will be relieved.
Study: NCT05415553

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: IOBT
Description: Surgery of inferior oblique muscle belly transposition for treatment of primary position hypertropia with inferior oblique overaction

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: IO-Rec
Description: Surgery of inferior oblique muscle recession for treatment of primary position hypertropia with inferior oblique overaction
Study: NCT04503941

Intervention type: DEVICE
Group type: PLACEBO_COMPARATOR
Intervention: False Needle treatment
Description: False Needle treatment treatment will be the Traditional Chinese Medicine type. Acupuncture 3 times per week, 4 weeks is one treatment period. Every patient will be given 3 treatment period.
Study: NCT05215314

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: mHealth Meditation
Description: Participants will receive access to the 4-week Healthy Minds Program (HMP) Foundations module. The HMP app is a meditation-based smartphone app designed to promote and protect psychological well-being through sustainable skills training. The program is grounded in constituents of psychological well-being identified in empirical literature. HMP provides core content, with instruction administered through a curriculum of guided practices. HMP is based on research on eudaimonic well-being (e.g., environmental mastery, purpose) and brain-based skills that underlie these qualities (e.g., regulation of attention, mental flexibility). The full HMP has guided audio practices that address 4 constituents of well-being: awareness, connection, insight, and purpose. At post-treatment, participants will be given access to additional HMP content to support their continued practice.
Study: NCT05969912

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Graston Technique (Instrumented assisted soft tissue mobilization)
Description: They would received Graston technique (Instrumented assisted soft tissue mobilization) as follow:~Using lubricant (Vaseline) on the skin then a stainless steel instrument to relax the fascia and muscles. Frequency: 60 reps per min for 3 times/week for 3 consecutive weeks Intensity: moderate intensity (pain free) Time: 20 mins Type: Graston technique (Instrument assisted soft tissue mobilization)~Additionally, the would receive Conventional PT :~Ultrasound for 5 min Stretching exercises at lumbar : Frequency: 10 reps with 5 sec hold for 3 times/week for 3 weeks

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Bowen's Technique(Soft tissue technique)
Description: They would received Bowen's technique (Soft tissue technique) as follow:~Bowen moves (15 - 20 times) with 2 mins gap between each set. Frequency: 3 times/week for 3 consecutive weeks Intensity: moderate intensity (pain free) Time: 20 mins Type: Bowen's technique (Soft tissue technique)~Additionally, the would receive Conventional PT :~Ultrasound for 5 min Stretching exercises at lumbar : Frequency: 10 reps with 5 sec hold for 3 times/week for 3 weeks
Study: NCT05766293

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: extracorporeal shockwave device
Description: Fibroblast cell lines (n=10) were subjected to Shockwaves from extracorporeal shockwave device
Study: NCT05140135

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Recovery Oriented Cognitive Therapy (CT-R)
Description: The CT-R that will be implemented in the present study will focus on strengthening aspirations and focusing on activities that can bring about one's desired life. In CT-R, clinicians use techniques to engage the patient in the adaptive mode, which includes cognitions, affects, motivation, and behaviors that are activated when the individual is engaged in personally meaningful activities.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Treatment as Usual
Description: All patients enrolled in the study who are randomized to the continued care as usual condition will continue to receive the treatments from their physician/treatment team at the Community Mental Health Center; however, they will not receive the adjunctive CT-R treatment.